PLoS One

Pterostilbene Acts Through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer.

Published March 8, 2013

Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer.

PLoS One. 2013; 8(3): e57542
Li K, Dias SJ, Rimando AM, Dhar S, Mizuno CS, Penman AD, Lewin JR, Levenson AS

The development… Continue reading →

Effectiveness of the Histone Deacetylase Inhibitor (S)-2 Against LNCaP and PC3 Human Prostate Cancer Cells.

Published March 8, 2013

Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells.

PLoS One. 2013; 8(3): e58267
Laurenzana A, Balliu M, Cellai C, Romanelli MN, Paoletti F

Histone deacetylase inhibitors (HDACi) represent a promising class of… Continue reading →

Walking Performance: Correlation Between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.

Published March 8, 2013

Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.

PLoS One. 2013; 8(2): e56669
Franceschini M, Rampello A, Agosti M, Massucci M, Bovolenta F, Sale P

Walking ability, though important for… Continue reading →

Neuropsychological and Socio-Occupational Functioning in Young Psychiatric Outpatients: A Longitudinal Investigation.

Published March 8, 2013

Neuropsychological and socio-occupational functioning in young psychiatric outpatients: a longitudinal investigation.

PLoS One. 2013; 8(3): e58176
Lee RS, Hermens DF, Redoblado-Hodge MA, Naismith SL, Porter MA, Kaur M, White D, Scott EM, Hickie IB

Clinical symptoms and neuropsychological deficits… Continue reading →

The Center for Epidemiologic Studies Depression Scale: A Review With a Theoretical and Empirical Examination of Item Content and Factor Structure.

Published March 8, 2013

The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure.

PLoS One. 2013; 8(3): e58067
Carleton RN, Thibodeau MA, Teale MJ, Welch PG, Abrams MP, Robinson T, Asmundson… Continue reading →

Monoaminergic and Neuropeptidergic Neurons Have Distinct Expression Profiles of Histone Deacetylases.

Published March 8, 2013

Monoaminergic and neuropeptidergic neurons have distinct expression profiles of histone deacetylases.

PLoS One. 2013; 8(3): e58473
Takase K, Oda S, Kuroda M, Funato H

Monoaminergic and neuropeptidergic neurons regulate a wide variety of behaviors, such as feeding, sleep/wakefulness behavior,… Continue reading →

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.

Published March 7, 2013

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.

PLoS One. 2013; 8(2):
Coll RC, O’Neill LA

[This corrects the article on p. e29539 in vol. 6.]. HubMed – drug

Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity Against Respiratory Syncytial Virus.

Published March 6, 2013

Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus.

PLoS One. 2013; 8(2): e56762
Geller R, Andino R, Frydman J

Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children, leading to significant morbidity… Continue reading →

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort.

Published March 6, 2013

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort.

PLoS One. 2013; 8(2): e57526
Tang S, Lv X, Zhang Y, Wu S, Yang Z, Xia Y, Tu D, Deng P, Ma Y, Chen D, Zhan… Continue reading →

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction.

Published March 6, 2013

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction.

PLoS One. 2013; 8(2): e56306
Loftis JM, Wilhelm CJ, Vandenbark AA, Huckans M

Relapse rates following current methamphetamine abuse treatments are very high (?40-60%), and the neuropsychiatric impairments… Continue reading →

Pterostilbene Acts Through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer.

Effectiveness of the Histone Deacetylase Inhibitor (S)-2 Against LNCaP and PC3 Human Prostate Cancer Cells.

Walking Performance: Correlation Between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.

Neuropsychological and Socio-Occupational Functioning in Young Psychiatric Outpatients: A Longitudinal Investigation.

The Center for Epidemiologic Studies Depression Scale: A Review With a Theoretical and Empirical Examination of Item Content and Factor Structure.

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.

Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity Against Respiratory Syncytial Virus.

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort.

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction.

Recent Posts

Search this Site